Literature DB >> 26608608

The calcium-sensing receptor and the hallmarks of cancer.

Samawansha Tennakoon1, Abhishek Aggarwal2, Enikö Kállay3.   

Abstract

The calcium-sensing receptor (CaSR) plays a pivotal role in systemic calcium metabolism by regulating parathyroid hormone secretion and urinary calcium excretion. The CaSR is ubiquitously expressed, implying a wide range of functions regulated by this receptor. Abnormal CaSR function affects the development of both calciotropic disorders such as hyperparathyroidism, and non-calciotropic disorders such as cardiovascular disease and cancer, which are the leading causes of mortality worldwide. The CaSR is able to bind a plethora of ligands; it interacts with multiple G protein subtypes, and regulates highly divergent downstream signalling pathways, depending on the cellular context. The CaSR is a key regulator for such diverse processes as hormone secretion, gene expression, inflammation, proliferation, differentiation, and apoptosis. Due to this pleiotropy, the CaSR is able to regulate cell fate and is implicated in the development of many types of benign or malignant tumours of the breast, prostate, parathyroid, and colon. In cancer, the CaSR appears to have paradoxical roles, and depending on the tissue involved, it is able to prevent or promote tumour growth. In tissues like the parathyroid or colon, the CaSR inhibits proliferation and induces terminal differentiation of the cells. Therefore, loss of the receptor, as seen in colorectal or parathyroid tumours, confers malignant potential, suggestive of a tumour suppressor role. In contrast, in prostate and breast tumours the expression of the CaSR is increased and it seems that it favours metastasis to the bone, acting as an oncogene. Deciphering the molecular mechanism driving the CaSR in the different tissues could lead to development of new allosteric drug compounds that selectively target the CaSR and have therapeutic potential for cancer. This article is part of a Special Issue entitled: Calcium and Cell Fate. Guest Editors: Jacques Haiech, Claus Heizmann, Joachim Krebs, Thierry Capiod and Olivier Mignen.
Copyright © 2015 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biased signalling; Calcium; Cancer; G protein-coupled receptors; Oncogene; Tumour suppressor

Mesh:

Substances:

Year:  2015        PMID: 26608608     DOI: 10.1016/j.bbamcr.2015.11.017

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  36 in total

1.  Exploring the prognostic significance of preoperative high normocalcemia in epithelial ovarian carcinoma.

Authors:  Hyun-Woong Cho; Yung-Taek Ouh; Jin Hwa Hong; Jae Kwan Lee
Journal:  Arch Gynecol Obstet       Date:  2020-10-19       Impact factor: 2.344

2.  Transcription factor c-Myb: novel prognostic factor in osteosarcoma.

Authors:  Kamila Říhová; Monika Dúcka; Iva Staniczková Zambo; Ladislava Vymětalová; Martin Šrámek; Filip Trčka; Jan Verner; Stanislav Drápela; Radek Fedr; Tereza Suchánková; Barbora Pavlatovská; Eva Ondroušková; Irena Kubelková; Danica Zapletalová; Štěpán Tuček; Peter Múdry; Dagmar Adámková Krákorová; Lucia Knopfová; Jan Šmarda; Karel Souček; Lubor Borsig; Petr Beneš
Journal:  Clin Exp Metastasis       Date:  2022-01-07       Impact factor: 5.150

3.  Case of Recurrent Primary Hyperparathyroidism, Congenital Granular Cell Tumor, and Aggressive Colorectal Cancer.

Authors:  Samina Afreen; Lee S Weinstein; William F Simonds; Smita Jha
Journal:  J Endocr Soc       Date:  2022-06-24

Review 4.  The Regulatory Roles of Mitochondrial Calcium and the Mitochondrial Calcium Uniporter in Tumor Cells.

Authors:  Linlin Zhang; Jingyi Qi; Xu Zhang; Xiya Zhao; Peng An; Yongting Luo; Junjie Luo
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

Review 5.  Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives.

Authors:  Ilaria Saltarella; Concetta Altamura; Aurelia Lamanuzzi; Benedetta Apollonio; Angelo Vacca; Maria Antonia Frassanito; Jean-François Desaphy
Journal:  Int J Mol Sci       Date:  2022-06-30       Impact factor: 6.208

6.  Mechanism of transmembrane and coiled-coil domain 1 in the regulation of proliferation and migration of A549 cells.

Authors:  Chen Yang; Yuan Wang; Jian-Qi Bai; Jing-Ru Zhang; Pei-Yan Hu; Yan Zhu; Qin Ouyang; Hong-Mei Su; Qiu-Yue Li; Ping Zhang
Journal:  Oncol Lett       Date:  2020-08-26       Impact factor: 2.967

7.  Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study.

Authors:  Fatemeh Momen-Heravi; Yohei Masugi; Zhi Rong Qian; Reiko Nishihara; Li Liu; Stephanie A Smith-Warner; NaNa Keum; Lanjing Zhang; Nairi Tchrakian; Jonathan A Nowak; Wanshui Yang; Yanan Ma; Michaela Bowden; Annacarolina da Silva; Molin Wang; Charles S Fuchs; Jeffrey A Meyerhardt; Kimmie Ng; Kana Wu; Edward Giovannucci; Shuji Ogino; Xuehong Zhang
Journal:  Int J Cancer       Date:  2017-09-20       Impact factor: 7.396

8.  Genetic polymorphism of calcium-sensing receptor in women with breast cancer.

Authors:  Larysse Maira Campos-Verdes; João Paulo da Silva-Sampaio; Danylo Rafhael Costa-Silva; Victor Alves de Oliveira; Airton Mendes Conde Junior; Vladimir Costa Silva; Airlane Pereira Alencar; Viriato Campelo; Pedro Vitor Lopes-Costa; Luiz Henrique Gebrim; Benedito Borges da Silva
Journal:  Med Oncol       Date:  2018-01-31       Impact factor: 3.064

9.  Calcium-Sensing Receptor Tumor Expression and Lethal Prostate Cancer Progression.

Authors:  Thomas U Ahearn; Nairi Tchrakian; Kathryn M Wilson; Rosina Lis; Elizabeth Nuttall; Howard D Sesso; Massimo Loda; Edward Giovannucci; Lorelei A Mucci; Stephen Finn; Irene M Shui
Journal:  J Clin Endocrinol Metab       Date:  2016-04-26       Impact factor: 5.958

Review 10.  The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases.

Authors:  Fadil M Hannan; Enikö Kallay; Wenhan Chang; Maria Luisa Brandi; Rajesh V Thakker
Journal:  Nat Rev Endocrinol       Date:  2018-12       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.